Article
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides
27 Dec 2018
Abstract excerpt
Nematodes causing lymphatic filariasis and onchocerciasis rely on their bacterial endosymbiont, Wolbachia, for survival and fecundity, making Wolbachia a promising therapeutic target. Here we perform a high-throughput screen of AstraZeneca's 1.3 million in-house compound library and identify 5 novel chemotypes with faster in vitro kill rates (<2 days) than existing anti-Wolbachia drugs that cure onchocerciasis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
